Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer Paul Gineste brings 25 years of experience in clinical development and strategy with leading international...

Diaccurate Announces the Appointment of Scott Filosi as CEO and Corporate Name Change to Evexta Bio Diaccurate Announces the Appointment of Scott Filosi as EVEXTA BIOCEO and Corporate Name Change to Evexta Bio Scott Filosi brings more than 30 years of experience in market access and...